Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1991-09-26
1993-03-02
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
530351, 424 855, 424 857, A61K 3766
Patent
active
051907518
ABSTRACT:
Human leukemia T-cells and B-cells are inhibited from proliferating by treatment with a combination of recombinant human alpha and gamma interferons, either simultaneously or sequentially, and the alpha interferon is preferably recombinant human alfa-2b interferon.
REFERENCES:
patent: 4289690 (1981-09-01), Pestka et al.
patent: 4503035 (1985-03-01), Pestka et al.
Fleishman et al., Antiviral Research, vol. 4, pp. 357-360, 1984.
Denz et al., J. Interferon Research, vol. 5, pp. 147-157, 1985.
Gray et al., Nature, 295 503-508 (1982).
Epstein, Nature, 295, 453-454 (1982).
Nagata et al., Nature, 284, 316-320 (1980).
Borden et al., Progress in Hematology, vol. XII, Brown, editor, pp. 299-339 (1981).
Gresser et al., Biochim, Biophys, Acta. 516, 231-247 (1978).
Gresser, Chemotherapy-A Comprehensive Treatise, Becher, F. editor vol. 5, pp. 521-571 (1977).
Einhorn et al., Human Interferon Production and Clinical Use, Stinebring et al., editors pp. 159-174 (1977).
Weigent et al., Inf., and Immun. 40 (1) 35-38 (1983).
Fleischmann, Jr. et al., J. Interferon Res. 4, 265-274 (1984).
Boxer Matthew
Guest Shelly J.
Hill Jr. Robert J.
Hoffman Thomas D.
Jeanette Henry C.
LandOfFree
Treatment of certain leukemias with a combination of gamma inter does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of certain leukemias with a combination of gamma inter, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of certain leukemias with a combination of gamma inter will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-125404